IKKα inhibitors constitute a distinct chemical class renowned for their capacity to selectively hinder the activity of IκB kinase α (IKKα), an enzyme pivotal in orchestrating intricate cellular processes. The inhibitors are meticulously designed molecules that interact with the active site of IKKα, impeding its phosphorylation of IκB proteins, which in turn averts the activation of the NF-κB signaling pathway. This molecular cascade plays a pivotal role in regulating gene expression linked to various physiological responses, including immune responses, inflammation, and cell survival. The chemical structures of IKKα inhibitors are characterized by intricate arrangements of functional groups that enable them to establish specific interactions with residues within the active site of the enzyme. These interactions, often involving hydrogen bonds, electrostatic interactions, and hydrophobic contacts, contribute to the inhibitors' selectivity for IKKα over other kinases.
The development of such inhibitors entails rigorous structure-activity relationship studies to fine-tune their binding affinity and specificity. Many IKKα inhibitors share common structural motifs, often involving heterocyclic rings or aromatic systems linked to various functional groups. These moieties are strategically positioned to interact with key residues in the active site, thus disrupting the kinase's catalytic activity. In conclusion, IKKα inhibitors represent a chemically diverse class of compounds that can modulate cellular signaling pathways by specifically targeting the IKKα enzyme. Their intricate structural designs and interactions with the active site contribute to their selectivity and effectiveness in inhibiting the NF-κB signaling cascade.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
BMS-345541 | 445430-58-0 | sc-221741 | 1 mg | $306.00 | 1 | |
An early Ikkα inhibitor with anti-inflammatory properties, showing promise in research studies. | ||||||
IKK-2 Inhibitor IV | 507475-17-4 | sc-203083 | 500 µg | $130.00 | 12 | |
A selective Ikkα inhibitor that has been investigated for its potential role in inflammatory diseases and cancer. | ||||||
Amlexanox | 68302-57-8 | sc-217630 | 10 mg | $160.00 | 2 | |
Originally developed for asthma and aphthous ulcers, it has been found to inhibit Ikkα and modulate inflammation. | ||||||
IMD 0354 | 978-62-1 | sc-203084 | 5 mg | $199.00 | 3 | |
A selective Ikkα inhibitor known for its anti-inflammatory effects, which have been studied in various models of inflammation. | ||||||
WS 3 | 39711-79-0 | sc-204401 sc-204401A | 25 g 100 g | $60.00 $141.00 | ||
A small-molecule Ikkα inhibitor studied for its role in inhibiting Ikkα-mediated NF-κB activation. | ||||||
ML 120B Dihydrochloride | 783348-36-7 (free base) | sc-487759 | 5 mg | $380.00 | ||
An Ikkα inhibitor that has shown potential in research studies as an anti-inflammatory agent. | ||||||
SKF 86002 | 72873-74-6 | sc-203265 | 5 mg | $153.00 | ||
An Ikkα inhibitor with potential anti-cancer properties due to its ability to suppress NF-κB activation. | ||||||
CCG 203971 | 1443437-74-8 | sc-507360 | 10 mg | $89.00 | ||
A selective Ikkα inhibitor that has been researched for its role in modulating inflammatory responses. | ||||||
TC-I 15 | 916734-43-5 | sc-474353 | 10 mg | $357.00 | ||
An Ikkα inhibitor that has shown promise in laboratory studies for its anti-inflammatory effects. | ||||||
STO-609 | 52029-86-4 | sc-507444 | 5 mg | $140.00 | ||
While primarily known as a CaMKK inhibitor, STO-609 also exhibits inhibitory activity against Ikkα, impacting the NF-κB pathway. | ||||||